Huons to promote Selenase

Published: 2013-07-09 06:57:00

Updated: 2013-07-09 06:57:00

Huons CEO Chun Jae-gap said last Wednesday that the drugmaker will step up efforts to promote Selenase (selenium) here, a drug used to enhance the immune system in a human body.

Huons established a strategic partnership with Biosyn Korea, a Korean unit of Arzneimittel GmbH in Germany, to sell ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK